ArticleSAGE open medical case reports2025
A rare epidermal growth factor receptor T790M/cis-C797S/L718Q compound mutation in a lung adenocarcinoma patient who did not derive any benefit from combination therapy with afatinib and bevacizumab.
Xiaopeng Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.